FDA Inspection 655775 — Anika Therapeutics, Inc.

Anika Therapeutics, Inc. — FEI 3007093114

The FDA completed an inspection of Anika Therapeutics, Inc. on Mar 12, 2010 in Bedford, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 12, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Bedford, MA (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.